Recent Price Trend in Metsera Inc. ( MTSR ) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Metsera Inc. (MTSR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session - ATAI Life Sciences ( NASDAQ:ATAI ) , Cantor Equity Partners I ( NASDAQ:CEPO )
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Monday. Shares of ATAI Life Sciences NV ATAI fell sharply in pre-market trading after the company announced the Phase 2b trial of Inidascamine in patients with cognitive impairment associated with ...
Wall Street Analysts See a 55.72% Upside in Metsera Inc. ( MTSR ) : Can the Stock Really Move This High?
The mean of analysts' price targets for Metsera Inc. (MTSR) points to a 55.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Methode Electronics, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - BitMine Immersion Techs ( AMEX:BMNR ) , Altimmune ( NASDAQ:ALT )
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares of Methode Electronics, Inc. MEI fell sharply in today's pre-market trading after the company reported a fourth-quarter adjusted EPS miss.
Nasdaq Welcomes 142 IPOs in the First Half of 2025
Highest volume of listings and capital raise in the first half of the year since ...
Nasdaq Welcomes 142 IPOs in the First Half of 2025
Nasdaq Welcomes 142 IPOs in the First Half of ...
Nasdaq Welcomes 142 IPOs in the First Half of 2025 - Nasdaq ( NASDAQ:NDAQ )
Highest volume of listings and capital raise in the first half of the year since 2021 Maintained leadership in switches - crossed $3 trillion in market value transferred since 2005 Driving smart policy reforms to improve regulatory processes for public companies
Wall Street Analysts See an 89.66% Upside in Metsera Inc. ( MTSR ) : Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 89.7% in Metsera Inc. (MTSR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday - AST SpaceMobile ( NASDAQ:ASTS ) , Couchbase ( NASDAQ:BASE )
U.S. stocks were mixed, with the Dow Jones index gaining over 50 points on Friday. Shares of The Kroger Co. KR rose sharply during Friday's session after the company reported better-than-expected first-quarter adjusted EPS results.
Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Metsera ( NASDAQ:MTSR )
NEW YORK, June 10, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc.
Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference
NEW YORK, June 10, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc. ( Nasdaq: MTSR ) ( "Metsera" or the "Company" ) , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit Bernard, its Chief Executive ...
Metsera Stock Rises As Company Advances Obesity Pipeline With Encouraging Weight Loss Data - Metsera ( NASDAQ:MTSR )
MET-233i shows 8.4% mean placebo-subtracted weight loss after five weekly 1.2 mg doses. MET-233i's 19-day half-life supports monthly dosing with favorable tolerability and no serious safety signals. Get access to the leaderboards pointing to tomorrow's biggest stock movers. Metsera, Inc.
Crude Oil Moves Higher; Graham Shares Surge After Q4 Results - Circle Internet Group ( NYSE:CRCL ) , Graham ( NYSE:GHM )
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday. The Dow traded up 0.04% to 42,779.63 while the NASDAQ gained 0.38% to 19,603.71. The S&P 500 also rose, gaining, 0.18% to 6,011.40. In trading on Monday, financial stocks fell by 0.5%.
Warner Bros. Discovery, Metsera, eToro Group And Other Big Stocks Moving Higher On Monday - Cameco ( NYSE:CCJ ) , AST SpaceMobile ( NASDAQ:ASTS )
U.S. stocks were mixed, with the Dow Jones index falling around 150 points on Monday. Shares of Warner Bros. Discovery, Inc. WBD rose sharply in today's session.
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Circle Internet Group ( NYSE:CRCL ) , Davis Commodities ( NASDAQ:DTCK )
Shares of Circle Internet Group CRCL rose sharply in today's pre-market trading on continued IPO launch strength.
Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i
Placebo-subtracted mean weight loss up to 8.4% at Day ...
Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®
Four presentations on MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, including two clinical data presentations ...
Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in ...
Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday - CECO Environmental ( NASDAQ:CECO ) , Crown Holdings ( NYSE:CCK )
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Tuesday. Shares of Honeywell International Inc. HON rose sharply during Tuesday's session after the company reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS guidance.
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs beginning ...
KB Home Posts Downbeat Results, Joins UniFirst, Oklo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - KB Home ( NYSE:KBH ) , China Yuchai Intl ( NYSE:CYD )
U.S. stock futures were mixed this morning, with the S&P 500 futures gaining around 0.1% on Tuesday. Shares of KB Home KBH fell sharply in today's pre-market trading as the company reported weaker-than-expected first-quarter results after the closing bell on Monday.
Science Applications Posts Better-Than-Expected Earnings, Joins Qifu Technology, Baidu, American Eagle And Other Big Stocks Moving Higher On Monday - Alpha Technology Group ( NASDAQ:ATGL ) , American Eagle Outfitters ( NYSE:AEO )
U.S. stocks were higher, with the Dow Jones index gaining around 350 points on Monday. Shares of Science Applications International Corporation SAIC rose sharply during Monday's session after the company reported better-than-expected fourth-quarter financial results.
The State of Weight Loss Drugs
In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss:To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our beginner's guide to investing in stocks.
Why Did MTSR Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing - Metsera ( NASDAQ:MTSR ) , Fidelity Nasdaq Composite Index ETF ( NASDAQ:ONEQ )
The newly listed clinical-stage biotechnology company, Metsera Inc. MTSR rose 15.01% on Monday as the broader markets declined. What Happened: While the company reported insider trades over the last month after its listing on Jan. 31, the stock has advanced 7.55% since it started trading on Nasdaq.
Metsera to Present at TD Cowen's 45th Annual Health Care Conference - Metsera ( NASDAQ:MTSR )
NEW YORK, Feb. 26, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc.
Metsera to Present at TD Cowen's 45th Annual Health Care Conference
NEW YORK, Feb. 26, 2025 ( GLOBE NEWSWIRE ) -- Metsera, Inc. ( Nasdaq: MTSR ) ( "Metsera" or the "Company" ) , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit Bernard, its Chief Executive ...
